|
VS-7375 Clinical Trials
4 actively recruiting trials across 1 location
▲ +1 trial since July 2026
Pipeline
Phase 2: 3Phase 1/2: 1
Top Sponsors
- Verastem, Inc.4
Indications
- Cancer4
- G12D Mutated KRAS2
- Colorectal Cancer2
- Lung Cancer2
- Non Small Cell Lung Cancer2
Los Angeles, California4 trials
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Cedars-Sinai Medical Center
Phase 1/2
Phase 2
Phase 2
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.